A Python-Inspired Molecule Suppresses Appetite After Eating

By Pooja Toshniwal PahariaReviewed by Lauren HardakerApr 2 2026

A metabolite first uncovered in pythons after massive meals is now shown to signal the brain to curb appetite in mammals, revealing a surprising gut–liver–brain pathway that could reshape how we understand, and eventually treat, obesity. 

Study: Python metabolomics uncovers a conserved postprandial metabolite and gut–brain feeding pathway. Image credit: Mark_Kostich/Shutterstock.com

A new study published in Nature Metabolism has identified para-tyramine-O-sulphate (pTOS) as a postprandial metabolite that rises after feeding and is conserved across pythons and humans, with appetite-suppressing effects demonstrated in mice.

Produced through a microbiome-dependent pathway in which gut microbes convert dietary tyrosine to tyramine and the liver subsequently sulfates it to pTOS, pTOS rises sharply after feeding and activates neurons in the ventromedial hypothalamus (VMH) involved in suppressing feeding. First observed at strikingly high levels in post-meal pythons, the metabolite is also present in humans. In mice, it suppresses feeding and, with sustained administration, lowers body weight in obese male models, highlighting a candidate metabolite pathway linking nutrient intake to neural control of feeding.

Newly Identified pTOS Links Feeding To Brain Signals

Current understanding of appetite regulation largely centers on hormonal signals such as leptin, insulin, and glucagon-like peptide-1 (GLP-1). The role of postprandial small-molecule metabolites in influencing brain function remains relatively underexplored. The gut microbiome–liver axis is known to generate bioactive compounds; however, its contribution to the production of conserved signaling metabolites that regulate feeding is not well defined.

Unlike mammals, which consume small, frequent meals, pythons exhibit pronounced and reversible metabolic shifts during feeding and fasting. These unique physiological features make them a valuable model for uncovering novel mediators that link nutrient intake to brain-regulated energy balance.

Multi-Species Metabolomics Identifies Postprandial Signaling Molecules

In this study, researchers combined untargeted and targeted metabolomics with cross-species and functional experiments to identify and characterize postprandial signaling molecules.

The team first analyzed plasma from fasted and fed Burmese pythons using liquid chromatography–mass spectrometry (LC–MS) to capture global metabolic changes. They applied a twofold cut-off to shortlist candidate metabolites. Tandem mass spectrometry (MS/MS) and comparison with synthetic standards confirmed metabolite identities. Subsequently, the team performed quantitative analyses to determine circulating concentrations.

To assess conservation, the team measured metabolite levels in ball pythons. In addition, they examined human postprandial responses using existing metabolomic datasets alongside targeted LC–MS measurements from controlled meal tests. To investigate biosynthesis, the investigators conducted tyrosine feeding experiments in pythons and cultured gut microbes under anaerobic conditions to assess metabolite production. Liver slice incubations and quantitative proteomics further mapped enzymatic pathways, while antibiotic treatment tested microbiome dependence. Molecular assays in cell systems validated key enzymatic steps.

The researchers also evaluated physiological function in mice through acute and chronic administration studies. They measured food intake, body weight, and metabolic parameters. Behavioral assays ruled out aversive effects. Neural activity mapping, chemogenetic silencing, and electrophysiology identified hypothalamic circuits involved in appetite regulation. Together, this integrated approach enabled the discovery and functional validation of a conserved metabolite linking nutrient intake to brain-controlled feeding.

pTOS Surges After Feeding And Suppresses Appetite

Untargeted metabolomics identified pTOS as the most strongly induced postprandial metabolite in Burmese pythons. Notably, pTOS levels increased by more than 1,000-fold after a single meal. Quantitative analyses showed that plasma levels rose from nanomolar concentrations in the fasted state to micromolar levels within 3 days of feeding. Structural validation using tandem MS and synthetic standards confirmed its identity. Similar postprandial spikes in ball pythons indicated evolutionary conservation.

Mechanistic experiments revealed a two-step biosynthetic pathway. Gut microbes convert dietary tyrosine to tyramine, which the liver subsequently sulfates to form pTOS. Tyrosine feeding increased circulating pTOS. In contrast, antibiotic-mediated microbiome depletion abolished its postprandial rise, confirming microbial dependence. Proteomic analyses further showed upregulation of sulfotransferases and related enzymes in the fed state.

Cross-species analyses detected pTOS in human circulation, with levels generally rising 2- to 5-fold after meals. However, responses were blunted or absent in individuals with prediabetes or type 2 diabetes. The pattern raises the possibility that postprandial pTOS regulation is altered in impaired glucose homeostasis. In contrast, endogenous pTOS was largely undetectable in mice, highlighting species-specific differences.

Functional studies demonstrated that exogenous pTOS reduced food intake in both lean and obese mice in a dose-dependent manner. Chronic administration led to sustained reduction in intake and approximately 9.0 % weight loss without aversive effects, and these effects were not explained by changes in major appetite-related hormones or nutrient absorption pathways.

Neurobiological assays showed that pTOS enters the brain and activates neurons in the ventromedial hypothalamus, a key appetite-regulating center, with additional activation observed in the paraventricular hypothalamus (PVH), although only VMH neurons were required for its anorexigenic effects. Silencing these neurons blunted its effects, supporting a conserved gut–liver–brain pathway with preclinical therapeutic relevance for obesity and metabolic disease.

Python Biology Uncovers New Preclinical Targets For Obesity 

This study positions pTOS as a previously unrecognized link between nutrient intake and neural control of feeding, expanding the framework of gut–brain communication beyond classical hormones. By tracing a microbiome–liver–brain pathway, the findings highlight how metabolite signaling may shape energy balance and suggest new therapeutic avenues for obesity and metabolic disorders, although current evidence is limited to preclinical models and early observational human data.

Looking ahead, key questions remain around the molecular targets of pTOS, its interaction with established hormonal pathways such as GLP-1, and the variability of its postprandial response in humans. Elucidating receptor mechanisms, neuronal specificity, and broader metabolic roles will be critical. More broadly, the work underscores the untapped potential of extreme physiological models and metabolite sulfation pathways as sources of novel, clinically relevant bioactive molecules.

Download your PDF copy by clicking here.

Journal Reference

Xiao, S. et al. (2026). Python metabolomics uncovers a conserved postprandial metabolite and gut–brain feeding pathway. Nature Metabolism, 1-16. DOI: 10.1038/s42255-026-01485-0. https://www.nature.com/articles/s42255-026-01485-0